Accounts Receivable, after Allowance for Credit Loss, Current of Thorne Healthtech, Inc. from 31 Dec 2020 to 30 Jun 2023

Taxonomy & unit
us-gaap: USD
Description
Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
Summary
Thorne Healthtech, Inc. quarterly Accounts Receivable, after Allowance for Credit Loss, Current in USD history and change rate from 31 Dec 2020 to 30 Jun 2023.
  • Thorne Healthtech, Inc. Accounts Receivable, after Allowance for Credit Loss, Current for the quarter ending 30 Jun 2023 was $25,406,854, a 146% increase year-over-year.
Source SEC data
View on sec.gov
Accounts Receivable, after Allowance for Credit Loss, Current, Quarterly (USD)
Accounts Receivable, after Allowance for Credit Loss, Current, YoY Quarterly Change (%)

Thorne Healthtech, Inc. Quarterly Accounts Receivable, after Allowance for Credit Loss, Current (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2023 $25,406,854 +$15,092,938 +146% 30 Jun 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 $18,991,679 +$9,832,770 +107% 31 Mar 2023 10-Q 12 May 2023 2023 Q1
Q4 2022 $14,367,785 +$9,082,464 +172% 31 Dec 2022 10-Q 09 Aug 2023 2023 Q2
Q3 2022 $13,411,032 +$7,726,700 +136% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 $10,313,916 30 Jun 2022 10-Q 10 Aug 2022 2022 Q2
Q1 2022 $9,158,909 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 $5,285,321 +$2,996,621 +131% 31 Dec 2021 10-K 31 Mar 2023 2022 FY
Q3 2021 $5,684,332 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q4 2020 $2,288,700 31 Dec 2020 10-K 16 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.